0 item(s)
View cart
You have no items in your shopping cart.
Description
GSK-LSD1, an LSD1 inhibitor, decreases food consumption and body weight while enhancing insulin sensitivity and glycemic regulation in murine obesity models. Additionally, it mitigates non-alcoholic fatty liver disease (NAFLD) and suppresses cytokine release induced by SARS-CoV-2 in COVID-19 peripheral blood mononuclear cells (PBMCs). Furthermore, GSK-LSD1 inhibits the proliferation and spread of cancer.
For research use only. We do not sell to patients.
Specification
| CAS Number | 1431368-48-7 |
| Molecular Weight | 289.24 |
| PubChem Substance ID | 329825454 |
| Purity | ≥98% |
| form | powder |
| color | white to beige |
| solubility | H2O: 20 mg/mL, clear |
| storage temp. | 2-8°C |
| SMILES string | C1(N[C@@H]2C[C@H]2C3=CC=CC=C3)CCNCC1 |
| InChI | 1S/C14H20N2/c1-2-4-11(5-3-1)13-10-14(13)16-12-6-8-15-9-7-12/h1-5,12-16H,6-10H2/t13-,14+/m0/s1 |
| InChI key | BASFYRLYJAZPPL-UONOGXRCSA-N |
When can I expect my order to ship?
Most orders are filled and shipped within 2-3 business days from the time they are received.
Our standard shipping usually take 2-5 days.
We also provide express shippping for time-sensitive deliveries.
Email contact@biofargo.com if you have any requirements.
No data
